Daiwa Securities Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4K | Hold |
127
| – | – | ﹤0.01% | 1166 |
|
2025
Q1 | $4K | Hold |
127
| – | – | ﹤0.01% | 1143 |
|
2024
Q4 | $4K | Hold |
127
| – | – | ﹤0.01% | 1171 |
|
2024
Q3 | $5K | Hold |
127
| – | – | ﹤0.01% | 1166 |
|
2024
Q2 | $4K | Hold |
127
| – | – | ﹤0.01% | 1201 |
|
2024
Q1 | $5K | Hold |
127
| – | – | ﹤0.01% | 1197 |
|
2023
Q4 | $4K | Hold |
127
| – | – | ﹤0.01% | 1212 |
|
2023
Q3 | $3K | Hold |
127
| – | – | ﹤0.01% | 1188 |
|
2023
Q2 | $3K | Hold |
127
| – | – | ﹤0.01% | 1209 |
|
2023
Q1 | $3K | Hold |
127
| – | – | ﹤0.01% | 1172 |
|
2022
Q4 | $3K | Hold |
127
| – | – | ﹤0.01% | 1183 |
|
2022
Q3 | $2K | Hold |
127
| – | – | ﹤0.01% | 1212 |
|
2022
Q2 | $2K | Buy |
127
+51
| +67% | +$803 | ﹤0.01% | 1217 |
|
2022
Q1 | $2K | Hold |
76
| – | – | ﹤0.01% | 1236 |
|
2021
Q4 | $1K | Hold |
76
| – | – | ﹤0.01% | 1323 |
|
2021
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 1234 |
|
2021
Q2 | $2K | Hold |
76
| – | – | ﹤0.01% | 1132 |
|
2021
Q1 | $2K | Hold |
76
| – | – | ﹤0.01% | 1138 |
|
2020
Q4 | $2K | Sell |
76
-104
| -58% | -$2.74K | ﹤0.01% | 1115 |
|
2020
Q3 | $4K | Hold |
180
| – | – | ﹤0.01% | 1092 |
|
2020
Q2 | $3K | Hold |
180
| – | – | ﹤0.01% | 1120 |
|
2020
Q1 | $3K | Hold |
180
| – | – | ﹤0.01% | 1123 |
|
2019
Q4 | $4K | Hold |
180
| – | – | ﹤0.01% | 1110 |
|
2019
Q3 | $2K | Hold |
180
| – | – | ﹤0.01% | 1110 |
|
2019
Q2 | $2K | Hold |
180
| – | – | ﹤0.01% | 1128 |
|
2019
Q1 | $3K | Hold |
180
| – | – | ﹤0.01% | 1091 |
|
2018
Q4 | $3K | Hold |
180
| – | – | ﹤0.01% | 1076 |
|
2018
Q3 | $3K | Hold |
180
| – | – | ﹤0.01% | 1086 |
|
2018
Q2 | $4K | Hold |
180
| – | – | ﹤0.01% | 1095 |
|
2018
Q1 | $5K | Buy |
+180
| New | +$5K | ﹤0.01% | 1063 |
|